El of phospho-JNK was not affected by HLJDT treatment (P.0.05, Fig.

El of phospho-JNK was not affected by HLJDT treatment (P.0.05, Fig. 8). Moreover, compared with the MS rats, phosphoAKT level was increased in both aspirin and HLJDT-treated rats (P,0.05, Fig. 8).Figure 4. Cardiac fibrosis measured by Sirius Red staining. The top panels showed representative images of Sirius Red-stained LV sections. A: NC group (n = 10); B: MS group (n = 10); C: MS+A group (n = 11); D: MS+H group (n = 11). The bottom bar graph showed quantitative interstitial fibrosis ratio. Each bar represented the mean 6SD. **P,0.01, *P,0.05 vs. NC; ##P,0.01, #P,0.05 vs MS. Original magnification, 6400. doi:10.1371/journal.pone.0067530.gFigure 5. Serum concentration of TNF-a measured by ELISA. The left bar graph indicated serum concentration of inflammatory cytokines before administration, while the right one indicated serum concentration of inflammatory cytokines after the administration of aspirin or HLJDT for 12 weeks. Each bar represented the mean 6SD. **P,0.01, *P,0.05 vs. NC; ##P,0.01, #P,0.05 vs. MS. NC group (n = 10); MS group (n = 10); MS+A group (n = 11); MS+H group (n = 11). doi:10.1371/journal.pone.0067530.gHuan-Lian-Jie-Du-Tang for Cardiac Damages in RatsFigure 6. Immunohistochemistry staining of ICAM-1 and NF-kB p65 in the heart. A,E: NC group (n = 10); B,F: MS group (n = 10); C,G: MS+A group (n = 11); D,H: 16985061 MS+H group (n = 11). The panels showed representative images of micrographs of immunohistochemistry staining in 4 groups. Original magnification, 6400. doi:10.1371/journal.pone.0067530.gDiscussionIn this study, we succeeded in producing MedChemExpress BTZ043 obesity and metabolic disturbances similar to those seen in human MS by feeding obesediet to rats. Based on this model we showed that MS caused significant myocardial lesions, increased the production of inflammatory cytokines and reduced insulin signaling in the heart. In previous study, we demonstrated that HLJDT treatment could inhibit inflammation and ameliorate MS-induced cardiac damage [15]. In the present study, we further investigated the mechanism by which HLJDT could improve IR, and compared the therapeutic effect between HLJDT and aspirin. The obese-diet used in the present study was a high-fat, highglucose and high-salt diet and sucrose solution, similar to the content of Western diets. We developed a MS model of rats with the following features: (1) Significant differences in BW between the obese-fed and normal-fed rats were developed from 20 weeks of age and persisted till 34 weeks. (2) Increased SBP was found in MS rats from 12 weeks of age, consistent with the classical features of MS [16]. (3) Low HDL-C was found in MS rats, while high TG and LDL-C were not found, suggesting that the lipid profile in MS rats is not exactly same as in human MS. (4) BTZ-043 elevated FBG, INSand IRI are regarded as a distinctive measure of IR. (5) The expression of inflammatory cytokines was increased and associated with increasing BW. These trends resembled those reported in human with obesity and IR. MS is defined by the cluster of several classic cardiovascular risk factors (such as hypertension, obesity, type 2 diabetes, high triglycerides and low HDL-C), and the underlying pathophysiology is thought to be related to IR 1676428 [17,2]. In the present study, the obese-fed rats developed obesity with low HDL-C as well as elevated BP, plasma glucose and insulin, which are considered as MS-related features. Therefore, this animal model is regarded as a model that mimics human MS and could be used to inve.El of phospho-JNK was not affected by HLJDT treatment (P.0.05, Fig. 8). Moreover, compared with the MS rats, phosphoAKT level was increased in both aspirin and HLJDT-treated rats (P,0.05, Fig. 8).Figure 4. Cardiac fibrosis measured by Sirius Red staining. The top panels showed representative images of Sirius Red-stained LV sections. A: NC group (n = 10); B: MS group (n = 10); C: MS+A group (n = 11); D: MS+H group (n = 11). The bottom bar graph showed quantitative interstitial fibrosis ratio. Each bar represented the mean 6SD. **P,0.01, *P,0.05 vs. NC; ##P,0.01, #P,0.05 vs MS. Original magnification, 6400. doi:10.1371/journal.pone.0067530.gFigure 5. Serum concentration of TNF-a measured by ELISA. The left bar graph indicated serum concentration of inflammatory cytokines before administration, while the right one indicated serum concentration of inflammatory cytokines after the administration of aspirin or HLJDT for 12 weeks. Each bar represented the mean 6SD. **P,0.01, *P,0.05 vs. NC; ##P,0.01, #P,0.05 vs. MS. NC group (n = 10); MS group (n = 10); MS+A group (n = 11); MS+H group (n = 11). doi:10.1371/journal.pone.0067530.gHuan-Lian-Jie-Du-Tang for Cardiac Damages in RatsFigure 6. Immunohistochemistry staining of ICAM-1 and NF-kB p65 in the heart. A,E: NC group (n = 10); B,F: MS group (n = 10); C,G: MS+A group (n = 11); D,H: 16985061 MS+H group (n = 11). The panels showed representative images of micrographs of immunohistochemistry staining in 4 groups. Original magnification, 6400. doi:10.1371/journal.pone.0067530.gDiscussionIn this study, we succeeded in producing obesity and metabolic disturbances similar to those seen in human MS by feeding obesediet to rats. Based on this model we showed that MS caused significant myocardial lesions, increased the production of inflammatory cytokines and reduced insulin signaling in the heart. In previous study, we demonstrated that HLJDT treatment could inhibit inflammation and ameliorate MS-induced cardiac damage [15]. In the present study, we further investigated the mechanism by which HLJDT could improve IR, and compared the therapeutic effect between HLJDT and aspirin. The obese-diet used in the present study was a high-fat, highglucose and high-salt diet and sucrose solution, similar to the content of Western diets. We developed a MS model of rats with the following features: (1) Significant differences in BW between the obese-fed and normal-fed rats were developed from 20 weeks of age and persisted till 34 weeks. (2) Increased SBP was found in MS rats from 12 weeks of age, consistent with the classical features of MS [16]. (3) Low HDL-C was found in MS rats, while high TG and LDL-C were not found, suggesting that the lipid profile in MS rats is not exactly same as in human MS. (4) Elevated FBG, INSand IRI are regarded as a distinctive measure of IR. (5) The expression of inflammatory cytokines was increased and associated with increasing BW. These trends resembled those reported in human with obesity and IR. MS is defined by the cluster of several classic cardiovascular risk factors (such as hypertension, obesity, type 2 diabetes, high triglycerides and low HDL-C), and the underlying pathophysiology is thought to be related to IR 1676428 [17,2]. In the present study, the obese-fed rats developed obesity with low HDL-C as well as elevated BP, plasma glucose and insulin, which are considered as MS-related features. Therefore, this animal model is regarded as a model that mimics human MS and could be used to inve.